CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
with stage I-IIIA Epithelial Growth Factor Receptor (EGFR) -mutant non-small cell lung cancer before sur ...
Phase 2
San Francisco, California, United States and 2 other locations
This is a Phase II, multi-center, open-label platform study evaluating novel combination treatment options in participants with locally advanced or m...
Phase 2
Santa Rosa, California, United States and 82 other locations
purpose of this study is to evaluate how well Rina-S works against lung cancer.The treatment in this study is Rina-S monotherapy (b...
Phase 2
Santa Rosa, California, United States and 73 other locations
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. The first t ...
Phase 3
San Francisco, California, United States and 16 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...
Phase 3
San Francisco, California, United States and 327 other locations
alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...
Phase 3
Santa Rosa, California, United States and 152 other locations
This is a pilot study using \[18F\]F AraG PET imaging to evaluate the immunological response to checkpoint inhibitor therapy (CkIT) in patients with...
Phase 2
Palo Alto, California, United States and 2 other locations
in combination with pembrolizumab in participants with advanced non-small cell lung cancer (NSCLC) or ho....
Phase 1
San Francisco, California, United States and 23 other locations
in subjects with locally advanced and unresectable or metastatic non-small cell lung cancer with a KRAS ...
Phase 1
San Francisco, California, United States and 37 other locations
resectable, early-stage non-small cell lung cancer....
Phase 2
Oakland, California, United States and 95 other locations
Clinical trials
Research sites
Resources
Legal